Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm reports global progress in phase 3 study

Jul 6, 2022 at 2:44 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment